Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-327-9 | CAS number: 105-75-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Toxicity Summary
Acute oral toxicity:
The acute oral toxicity (LD50) is 8530 mg per kg body weight in rats.
Acute dermal toxicity:
The acute dermal toxicity (LD50) is 15.9 mL per kg body weight in rabbits.
Acute toxicity, inhalation:
Rats exposed for 8 hours to saturated vapours of the test substance survived. No mortalities occurred. Therefore the acute toxicity via inhalation is considered to be very low.
Repeated dose toxicity:
NOAEL (rat, oral, 90 d) = 50 mg/kg bw/day (adverse effects kidney)
Reproductive toxicity
NOAEL (rat, developmental toxicity) > 750 mg/kg bw/day (highest dose tested, no developmental toxicity reported)
NOAEL (rat, maternal toxicity) = 250 mg/kg bw/day (body weight and food intake)
Genetic toxicity
The test item gave negative results in one bacterial gene mutation test, one in vitro cytogenetic study and one in vitro gene mutation study, regardless whether tested without or with the addition of metabolizing enzymes.
Toxicokinetic summary
Absorption / distribution
No indication for absorption in the gastrointestinal tract are derived from the results of the acute oral toxicity study. Although the log Pow is relatively high (4.62) and the water solubility is low (11.09 mg/L) uptake via the skin is considered to be low (LD50,dermal,rabbit 15.9 mL/kg bw).
Metabolism
No relevant differences occurred in the three mutagenicity studies with and without the addition of a metabolising system. Therefore no indication of the importance of the metabolism of the test item was obtained from these studies. DBF is expected to be metabolized rapidly in the human body and there is no expectation of desintegration into toxic cleavage products.
Excretion
No information is available on excretion of the test item.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
